Beijing Chunlizhengda Medical Instruments Future Growth
Future criteria checks 3/6
Beijing Chunlizhengda Medical Instruments is forecast to grow earnings and revenue by 15.7% and 17.2% per annum respectively. EPS is expected to grow by 15.9% per annum. Return on equity is forecast to be 9.6% in 3 years.
Key information
15.7%
Earnings growth rate
15.93%
EPS growth rate
| Medical Equipment earnings growth | 48.2% |
| Revenue growth rate | 17.2% |
| Future return on equity | 9.60% |
| Analyst coverage | Low |
| Last updated | 02 Nov 2025 |
Recent future growth updates
Recent updates
Optimistic Investors Push Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Shares Up 28% But Growth Is Lacking
Nov 10
Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) P/E Is Still On The Mark Following 34% Share Price Bounce
Aug 11Returns On Capital Signal Tricky Times Ahead For Beijing Chunlizhengda Medical Instruments (HKG:1858)
Aug 07Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jul 22Market Participants Recognise Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Earnings Pushing Shares 30% Higher
Jun 16There May Be Some Bright Spots In Beijing Chunlizhengda Medical Instruments' (HKG:1858) Earnings
Apr 04Time To Worry? Analysts Are Downgrading Their Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Outlook
Apr 03Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture
Feb 11Investors Still Waiting For A Pull Back In Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Sep 30Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858) Analysts Just Slashed This Year's Revenue Estimates By 13%
Sep 11Beijing Chunlizhengda Medical Instruments' (HKG:1858) Upcoming Dividend Will Be Larger Than Last Year's
Jul 01The Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Don't Inspire Confidence
May 25We Think You Can Look Beyond Beijing Chunlizhengda Medical Instruments' (HKG:1858) Lackluster Earnings
Apr 04Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Shareholders Might Be Looking For Exit
Jan 06Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture
Dec 06Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture
Aug 31Here's What's Concerning About Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns On Capital
Apr 11Here's What To Make Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Decelerating Rates Of Return
Dec 05Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Have Hit The Brakes
Apr 28I Built A List Of Growing Companies And Beijing Chunlizhengda Medical Instruments (HKG:1858) Made The Cut
Dec 30Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger
Dec 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 1,515 | 335 | 336 | 264 | 3 |
| 12/31/2026 | 1,270 | 271 | 309 | 63 | 3 |
| 12/31/2025 | 1,062 | 219 | 149 | 180 | 3 |
| 9/30/2025 | 1,054 | 255 | 124 | 190 | N/A |
| 6/30/2025 | 913 | 160 | 151 | 209 | N/A |
| 3/31/2025 | 814 | 128 | -2 | 52 | N/A |
| 12/31/2024 | 806 | 125 | -51 | -2 | N/A |
| 9/30/2024 | 925 | 158 | 450 | 481 | N/A |
| 6/30/2024 | 1,048 | 231 | 446 | 482 | N/A |
| 3/31/2024 | 1,184 | 277 | 457 | 502 | N/A |
| 12/31/2023 | 1,209 | 278 | 478 | 512 | N/A |
| 9/30/2023 | 1,234 | 279 | 129 | 131 | N/A |
| 6/30/2023 | 1,171 | 277 | 67 | 84 | N/A |
| 3/31/2023 | 1,191 | 290 | -64 | -59 | N/A |
| 12/31/2022 | 1,202 | 308 | 16 | 41 | N/A |
| 9/30/2022 | 1,150 | 328 | -43 | 30 | N/A |
| 6/30/2022 | 1,197 | 324 | -49 | 64 | N/A |
| 3/31/2022 | 1,139 | 328 | -34 | 134 | N/A |
| 12/31/2021 | 1,108 | 322 | -35 | 165 | N/A |
| 9/30/2021 | 984 | 287 | -10 | 177 | N/A |
| 6/30/2021 | 1,013 | 322 | 137 | 256 | N/A |
| 3/31/2021 | 1,007 | 318 | 227 | 303 | N/A |
| 12/31/2020 | 938 | 283 | 237 | 261 | N/A |
| 9/30/2020 | 913 | 264 | 173 | 249 | N/A |
| 6/30/2020 | 887 | 244 | 109 | 238 | N/A |
| 3/31/2020 | 826 | 216 | 69 | 191 | N/A |
| 12/31/2019 | 855 | 237 | 99 | 232 | N/A |
| 9/30/2019 | 758 | 201 | 68 | 161 | N/A |
| 6/30/2019 | 660 | 164 | N/A | 91 | N/A |
| 3/31/2019 | 579 | 135 | N/A | 100 | N/A |
| 12/31/2018 | 498 | 106 | N/A | 109 | N/A |
| 9/30/2018 | 444 | 94 | N/A | 111 | N/A |
| 6/30/2018 | 389 | 83 | N/A | 113 | N/A |
| 3/31/2018 | 345 | 76 | N/A | 102 | N/A |
| 12/31/2017 | 300 | 68 | N/A | 90 | N/A |
| 9/30/2017 | 261 | 65 | N/A | 86 | N/A |
| 6/30/2017 | 221 | 63 | N/A | 82 | N/A |
| 3/31/2017 | 215 | 63 | N/A | 73 | N/A |
| 12/31/2016 | 208 | 63 | N/A | 65 | N/A |
| 9/30/2016 | 201 | 55 | N/A | 46 | N/A |
| 6/30/2016 | 195 | 47 | N/A | 27 | N/A |
| 3/31/2016 | 186 | 43 | N/A | 13 | N/A |
| 12/31/2015 | 177 | 38 | N/A | -1 | N/A |
| 9/30/2015 | 179 | 47 | N/A | 7 | N/A |
| 6/30/2015 | 163 | 44 | N/A | -16 | N/A |
| 3/31/2015 | 149 | 41 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1858's forecast earnings growth (15.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 1858's earnings (15.7% per year) are forecast to grow faster than the Hong Kong market (12.3% per year).
High Growth Earnings: 1858's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1858's revenue (17.2% per year) is forecast to grow faster than the Hong Kong market (8.4% per year).
High Growth Revenue: 1858's revenue (17.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1858's Return on Equity is forecast to be low in 3 years time (9.6%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/17 03:40 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Chunlizhengda Medical Instruments Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wai Ming Kong | DBS Bank Ltd |
| Xibing Chen | Guosen Securities Co., Ltd. |
| Chao Zhang | Guosen Securities Co., Ltd. |